Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|22|2716-2730

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.22, 2011-11, pp. : 2716-2730

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 18, Iss. 32, 2011-11 ,pp. : 4949-4975

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

By  

Current Neuropharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 239-255

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer’s Disease Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 537-548

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer’s Disease: An Update

By  

Current Medicinal Chemistry, Vol. 25, Iss. 29, 2018-09 ,pp. : 3491-3525

Bentham Science Publishers

Access to resources Recommend Favorite

From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer’s Disease

By  

Current Medicinal Chemistry, Vol. 22, Iss. 33, 2015-11 ,pp. : 3789-18

Bentham Science Publishers

Access to resources Recommend Favorite